You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 8, February 24, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (91)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Randomized Double-blind Trial of Intravenous Prochlorperazine for the Treatment of Acute Headache

Jeffrey Jones, MD; David Sklar, MD; James Dougherty, MD; William White, MD

JAMA. 1989;261(8):1174-1176.


Abstract

In a prospective, randomized, double-blind clinical trial, intravenous prochlorperazine edisylate (Compazine Edisylate) was compared with a placebo in the treatment of severe headaches. Eighty-two adult patients with vascular or tension-type headaches were identified at the time of presentation to one of three participating emergency departments. After the patient gave informed consent, a 2-mL intravenous injection of sterile saline solution or prochlorperazine edisylate (10 mg) was given to each patient at the time of randomization. The treatment groups were similar with regard to age, sex, and type and duration of headache. Within 60 minutes after injection, 74% (31/42) of those who received prochlorperazine had complete relief; 14% (6/42) of the patients had partial relief. Overall, there was complete or partial relief of pain in 88% (37/42) of the drug group and in 45% (18/40) of the placebo group. This difference was statistically significant using {chi}2 analysis. Adverse effects were minimal; one patient experienced asymptomatic orthostatic hypotension. These results suggest that intravenous prochlorperazine is an effective treatment for patients with severe vascular or tension headaches who present to the emergency department.

(JAMA 1989;261:1174-1176)



Author Affiliations

From the Departments of Emergency Medicine, Butterworth Hospital, Grand Rapids, Mich (Dr Jones), Akron (Ohio) General Medical Center (Dr Dougherty), and Timken Mercy Hospital, Canton, Ohio (Dr White); and the Division of Emergency Medicine, University of New Mexico Hospital, Albuquerque (Dr Sklar).


Footnotes

Reprint requests to the Butterworth Hospital, 100 Michigan NE, Grand Rapids, MI 49503 (Dr Jones).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Practical Approach to Headache Treatment
Tucker
Journal of Pharmacy Practice 2007;20:123-136.
ABSTRACT  

Pediatric Migraine: Recognition and Treatment
Hershey and Winner
JAOA: Journal of the American Osteopathic Association 2005;105:2S-8S.
ABSTRACT | FULL TEXT  

Tolerability and Effectiveness of Prochlorperazine for Intractable Migraine in Children
Kabbouche et al.
Pediatrics 2001;107:e62-e62.
ABSTRACT | FULL TEXT  

Migraine: pharmacotherapy in the emergency department
Kelly
Emerg. Med. J. 2000;17:241-245.
ABSTRACT | FULL TEXT  

Drug Therapy of Migraine
Welch
NEJM 1993;329:1476-1483.
FULL TEXT  

PROCHLORPERAZINE EFFECTIVE FOR ACUTE HEADACHE
JWatch General 1989;1989:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.